Gundersen Lutheran Proposal to Join the Community Clinical Oncology Program

描述（由申请人提供）：Gundersen Lutheran癌症和血液疾病中心位于威斯康星州的拉克罗斯，为威斯康星州西部、爱荷华州东北部和明尼苏达州东南部的19个县的560，000名主要农村人口提供癌症护理。在这个三州地区服务的人口中有很大一部分被认为是医疗服务不足的人口或生活在卫生和人类服务部指定的卫生专业人员短缺地区。在拉克罗斯以外的县中，70%、60%、20%和5%被认为是由于地理区域、低收入、教养设施的存在或有美洲原住民部落人口而受到卫生和公众服务部的服务不足。大约3%的人口来自少数民族，包括苗族，美洲原住民和西班牙裔。拟议的社区临床肿瘤学计划（CCOP）的核心将由5名医学肿瘤学家、4名血液学家和4名放射肿瘤学家组成，他们都受雇于同一个卫生系统。该集团拥有强大的临床研究历史，拥有超过30年的临床试验经验，招募了1200多名患者进入国家癌症研究所（NCI）（ECOG，RTOG，COG，GOG，ACOSOG和CTSU）和行业赞助的试验。为了与NCI国家社区癌症中心计划保持一致并对其进行补充，拟议的CCOP将通过以下行动计划提高其服务人群的临床试验收益：1）通过在农村推广站点实施研究基础设施，为更广泛的地理区域提供临床试验; 2）通过与新的CCOP研究基地建立联系，增加癌症控制/预防和治疗试验的收益; 3）通过提供教育和癌症筛查机会，提高少数群体的研究参与度;以及4）通过在各种多学科癌症会议期间定期提高临床试验意识，提高其他医学专业的护理提供者对临床试验（特别是癌症控制/预防试验）的参与度。我们希望超过所需的最低累积数量，并满足质量保证和人类受试者安全的标准要求。 相关性：我们提议的CCOP将为中西部的农村人口提供并增强临床试验的可及性，这些农村人口主要由于地理障碍而服务不足。在一个广阔的地区，少数民族群体（美洲原住民，苗族和西班牙裔）的几个口袋也将成为目标。

DESCRIPTION (provided by applicant): The Gundersen Lutheran Center for Cancer and Blood Disorders, located in La Crosse, Wisconsin, provides cancer care for a predominantly rural population of 560,000 comprising 19 counties in western Wisconsin, northeastern lowa, and southeastern Minnesota. A substantial proportion of the population served in this Tri- state area is considered a Medically Underserved Population or lives in a Health Professional Shortage Area, as designated by the Department of Health and Human Services (DHHS). Of the counties outside of La Crosse, 70%, 60%, 20%, and 5% are considered underserved by DHHS due to geographical area, low income, presence of a correctional facility, or having a Native American tribal population, respectively. Approximately 3% of the population is from ethnic minority groups including Hmong, Native American, and Hispanic. The core of the proposed Community Clinical Oncology Program (CCOP) will be composed of 5 medical oncologists, 4 hematologists, and 4 radiation oncologists, all of whom are employed by the same health system. The group has a strong history of clinical research, with over 30 years of clinical trial experience enrolling over 1200 patients into National Cancer Institute (NCI) (ECOG, RTOG, COG, GOG, ACOSOG, and CTSU) and industry-sponsored trials. In alignment with and complementary to its NCI National Community Cancer Centers Program, the proposed CCOP will enhance clinical trial accrual among the population it serves with the following action plans: 1) offer clinical trial access to a wider geographic area by implementing research infrastructures in rural outreach sites; 2) increase accrual to cancer control/prevention and treatment trials by forming affiliations with new CCOP research bases; 3) improve research participation of minority groups by providing education and cancer screening opportunities; and 4) enhance clinical trial participation (especially to cancer control/prevention trials) among care providers from other medical specialties by regularly promoting clinical trial awareness during various multidisciplinary cancer conferences. We expect to exceed the minimum number of required accrual and meet standard requirements for quality assurance and human subject safety. RELEVANCE: Our proposed CCOP will provide and enhance clinical trial access to a rural population in the Midwest, predominantly underserved due to geographical barriers. Several pockets of minority groups (Native American, Hmong, and Hispanic) across a wide area will also be targeted.